SCANGOS GEORGE A Insider Trading Activity

Average Profitability
51.69%
Insider Buys Quantity
1
Insider Buys Sum
$80,000.00
Insider Sells Quantity
302
Insider Sells Sum
$94.9M

Insider Activity of SCANGOS GEORGE A

Biography of SCANGOS GEORGE A

No biography is available at this moment.

2025-02-24SaleVir Biotechnology, Inc.
VIR
director
10,056
0.0072%
$9.45$95,063-39.7%
2025-02-18SaleVir Biotechnology, Inc.
VIR
director
10,964
0.0081%
$9.81$107,575-41.07%
2024-02-26SaleVir Biotechnology, Inc.
VIR
director
17,722
0.0129%
$11.65$206,522-23.53%
2024-02-22SaleVir Biotechnology, Inc.
VIR
director
10,028
0.0073%
$10.05$100,737-11.7%
2024-02-20SaleVir Biotechnology, Inc.
VIR
director
16,872
0.0126%
$10.22$172,385-11.05%
2024-02-16SaleVir Biotechnology, Inc.
VIR
director
10,878
0.0081%
$10.24$111,386-11.32%
2023-02-24SaleVir Biotechnology, Inc.
VIR
President and CEO
15,119
0.0115%
$23.33$352,682-44.43%
2023-02-23SaleVir Biotechnology, Inc.
VIR
President and CEO
12,631
0.0095%
$25.97$328,065-50.21%
2023-02-21SaleVir Biotechnology, Inc.
VIR
President and CEO
17,856
0.0141%
$28.30$505,318-52.24%
2023-02-17SaleVir Biotechnology, Inc.
VIR
President and CEO
9,894
0.0073%
$25.29$250,199-49.88%
2022-02-18SaleVir Biotechnology, Inc.
VIR
President and CEO
17,726
0.0137%
$30.65$543,304-16.66%
2022-02-17SaleVir Biotechnology, Inc.
VIR
President and CEO
10,024
0.0078%
$31.93$320,074-18.84%
2020-05-18SaleExelixis, Inc.
EXEL
director
75,000
0.0246%
$25.96$1.95M-11.19%
2020-04-24SaleExelixis, Inc.
EXEL
director
15,000
0.0048%
$26.24$393,600-14.02%
2020-04-23SaleExelixis, Inc.
EXEL
director
100,000
0.032%
$25.99$2.6M-13.48%
2020-04-22SaleExelixis, Inc.
EXEL
director
4,200
0.0014%
$25.05$105,210-7.71%
2020-04-21SaleExelixis, Inc.
EXEL
director
5,800
0.0019%
$25.04$145,232-7.11%
2020-04-20SaleExelixis, Inc.
EXEL
director
50,000
0.0165%
$23.89$1.19M-3.22%
2020-04-15SaleExelixis, Inc.
EXEL
director
25,000
0.0082%
$18.31$457,750+24.95%
2020-04-08SaleExelixis, Inc.
EXEL
director
7,065
0.0023%
$18.35$129,643+21.63%
Total: 303
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.